Related Experiment Videos
Linkage of adrenoleukodystrophy to a polymorphic DNA probe
Annals of Neurology
|April 1, 1987
Summary
Researchers identified a genetic marker (St14) linked to X-linked adrenoleukodystrophy, enabling accurate carrier status determination for at-risk family members. This genetic linkage analysis supplements existing biochemical tests for the disease.
Area of Science:
- Genetics
- Molecular Biology
- Medical Research
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a severe genetic disorder affecting the adrenal glands and nervous system.
- Accurate carrier status determination is crucial for genetic counseling and family planning in X-ALD.
- Existing diagnostic methods, such as very-long-chain fatty acid measurement, can be supplemented by genetic linkage analysis.
Purpose of the Study:
- To establish genetic linkage between X-linked adrenoleukodystrophy and a specific DNA fragment (St14).
- To determine the precise location of the X-ALD gene on the X chromosome.
- To develop a reliable genetic marker for carrier status assignment in at-risk families.
Main Methods:
- Linkage analysis was performed using six families with X-linked adrenoleukodystrophy.
- A cloned deoxyribonucleic acid fragment (St14) was used to detect polymorphisms in the X chromosome's distal long arm (Xq27-28).
- Recombination rates and lod scores were calculated to assess genetic linkage.
Main Results:
- No recombination was observed between X-linked adrenoleukodystrophy and the St14 DNA fragment in six families studied.
- A lod score of 13.766 at a recombination fraction of 0.0 was calculated, indicating strong genetic linkage.
- The St14 marker is located in the Xq27-28 region, closely linked to the X-ALD gene.
Conclusions:
- The St14 DNA fragment serves as a reliable genetic marker for X-linked adrenoleukodystrophy.
- This genetic marker allows for accurate assignment of carrier status in at-risk individuals.
- The findings enhance diagnostic capabilities for X-linked adrenoleukodystrophy, complementing biochemical assessments.